Mary Owens - Concepedia

Author

Mary Owens

3M (United States)

Also Known As

M L Owens, M OWENS, M Owens, M. L. Owens, M. Owens, M.L Owens, M.L. Owens, MARY L. OWENS, MARY OWENS, Mary L. Owens

Publications

Citations

H-Index

Concepts

All Affiliations

3M (United States)University of California, San Francisco Vanderbilt University Harvard University Central State Hospital

About

Mary Owens is an author at 3M (United States) specializing in medicine, dermatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	2.7K
2	Health Sciences	2	2	65
3	Social Sciences	2	2	177
4	Biochemistry	2	2	91
5	Allergy	1	1	21

Mary Owens

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies John K. Geisse, Ivor Caro, Jane S. Lindholm, Journal of the American Academy of Dermatology MedicineImiquimod 5Phase IiiMelanomaDermatology	2004	504
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream Karl R. Beutner, John K. Geisse, Donita Helman, Journal of the American Academy of Dermatology Immune Response ModifierCancer ImmunosurveillanceMedicineImmunologyTherapeutic Response	1999	371
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial Robin Marks, Kurt Gebauer, Stephen Shumack, Journal of the American Academy of Dermatology MedicineImiquimod 5Clinical DermatologyDermatologyOncology	2001	343
Treatment of genital warts with an immune-response modifier (imiquimod) Karl R. Beutner, Spotswood L. Spruance, Andrina J. Hougham, Journal of the American Academy of Dermatology Primary ImmunodeficiencyClinical ImmunologyVaccinationImmunologyGenital Warts	1998	305
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study* John K. Geisse, Phoebe Rich, Amit G. Pandya, Journal of the American Academy of Dermatology Surgical OncologyMedicineImiquimod 5MelanomaPathology	2002	285
Imiquimod 5% cream in the treatment of Bowen's disease Andrew R MacKenzie‐Wood, Steven Kossard, J De Launey, Journal of the American Academy of Dermatology Imiquimod 5HistopathologyClinical DermatologyDermatologyMedicine	2001	268
Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts Karl R. Beutner, Stephen K. Tyring, Kenneth F. Trofatter, Antimicrobial Agents and Chemotherapy	1998	224
Mortality Associated with Implantation and Management of Intrathecal Opioid Drug Infusion Systems to Treat Noncancer Pain Robert J. Coffey, Mary Owens, Steven K. Broste, Anesthesiology	2009	125
A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily Philip Savage, Vicki L. Horton, J. Moore, British Journal of Cancer ImmunodeficienciesImmunologyOral Interferon InducerPharmacotherapyMedicine	1996	107
On the mechanism of amphetamine potentiation by desipramine (DMI) Fridolin Sulser, Mary Owens, James V. Dingell Life Sciences Psychoactive DrugAddictionMedicinePsychopharmacologyNeuropharmacology	1966	97

Page 1